Literature DB >> 21474597

Daily left prefrontal repetitive transcranial magnetic stimulation for acute treatment of medication-resistant depression.

Mark S George1, Robert M Post.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 21474597     DOI: 10.1176/appi.ajp.2010.10060864

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  35 in total

1.  Low frequency repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex transiently increases cue-induced craving for methamphetamine: a preliminary study.

Authors:  Xingbao Li; Robert J Malcolm; Kristina Huebner; Colleen A Hanlon; Joseph J Taylor; Kathleen T Brady; Mark S George; Ronald E See
Journal:  Drug Alcohol Depend       Date:  2013-08-26       Impact factor: 4.492

2.  Repetitive transcranial magnetic stimulation (rTMS) augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant obsessive-compulsive disorder (OCD): a meta-analysis of randomized controlled trials.

Authors:  Zhong-Rui Ma; Li-Jun Shi
Journal:  Int J Clin Exp Med       Date:  2014-12-15

3.  What is the role of brain stimulation therapies in the treatment of depression?

Authors:  Daniel M Blumberger; Benoit H Mulsant; Zafiris J Daskalakis
Journal:  Curr Psychiatry Rep       Date:  2013-07       Impact factor: 5.285

4.  Repetitive transcranial magnetic stimulation over the dorsolateral prefrontal cortex for treating posttraumatic stress disorder: an exploratory meta-analysis of randomized, double-blind and sham-controlled trials.

Authors:  Marcelo T Berlim; Frederique Van Den Eynde
Journal:  Can J Psychiatry       Date:  2014-09       Impact factor: 4.356

5.  Repetitive transcranial magnetic stimulation (rTMS) of the dorsolateral prefrontal cortex reduces resting-state insula activity and modulates functional connectivity of the orbitofrontal cortex in cigarette smokers.

Authors:  Xingbao Li; Lian Du; Gregory L Sahlem; Bashar W Badran; Scott Henderson; Mark S George
Journal:  Drug Alcohol Depend       Date:  2017-02-28       Impact factor: 4.492

Review 6.  Clinically meaningful efficacy and acceptability of low-frequency repetitive transcranial magnetic stimulation (rTMS) for treating primary major depression: a meta-analysis of randomized, double-blind and sham-controlled trials.

Authors:  Marcelo T Berlim; Frederique Van den Eynde; Z Jeff Daskalakis
Journal:  Neuropsychopharmacology       Date:  2012-11-19       Impact factor: 7.853

7.  Magnetic brain stimulation using iron oxide nanoparticle-mediated selective treatment of the left prelimbic cortex as a novel strategy to rapidly improve depressive-like symptoms in mice.

Authors:  Qing-Bo Lu; Jian-Fei Sun; Qu-Yang Yang; Wen-Wen Cai; Meng-Qin Xia; Fang-Fang Wu; Ning Gu; Zhi-Jun Zhang
Journal:  Zool Res       Date:  2020-07-18

8.  Consensus Recommendations for the Clinical Application of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Depression.

Authors:  Shawn M McClintock; Irving M Reti; Linda L Carpenter; William M McDonald; Marc Dubin; Stephan F Taylor; Ian A Cook; John O'Reardon; Mustafa M Husain; Christopher Wall; Andrew D Krystal; Shirlene M Sampson; Oscar Morales; Brent G Nelson; Vassilios Latoussakis; Mark S George; Sarah H Lisanby
Journal:  J Clin Psychiatry       Date:  2018 Jan/Feb       Impact factor: 4.384

9.  Repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex reduces nicotine cue craving.

Authors:  Xingbao Li; Karen J Hartwell; Max Owens; Todd Lematty; Jeffrey J Borckardt; Colleen A Hanlon; Kathleen T Brady; Mark S George
Journal:  Biol Psychiatry       Date:  2013-02-26       Impact factor: 13.382

Review 10.  The Clinical TMS Society Consensus Review and Treatment Recommendations for TMS Therapy for Major Depressive Disorder.

Authors:  Tarique Perera; Mark S George; Geoffrey Grammer; Philip G Janicak; Alvaro Pascual-Leone; Theodore S Wirecki
Journal:  Brain Stimul       Date:  2016-03-16       Impact factor: 8.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.